RxDoctor Payments Data

William McGlothlin, MD

Psychiatry · Manassas, VANPI 1174791859

Payments from drug & device makers

$1,079in general payments, 2019–2025

Across 47 payments — averaging $22.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$399
  • Alkermes, Inc.$232
  • Teva Pharmaceuticals USA, Inc.$145
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$108
  • Otsuka America Pharmaceutical, Inc.$99
  • Lundbeck LLC$51
  • plus $46 from 1 others

What the payments were for

  • Food & beverage$1,079100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,079 in reported general payments places this provider in the 75th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$2,051
Medicare patients
15
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate22$66,556
AristadaAripiprazole Lauroxil19$51,266
Aripiprazole79$5,193
Haloperidol87$2,301
Benztropine Mesylate82$945
Haloperidol Decanoate16$905
Divalproex Sodium38$633
Quetiapine Fumarate51$600
Risperidone38$434
Mirtazapine27$412
Divalproex Sodium ErDivalproex Sodium18$357
Duloxetine Hcl14$345
Olanzapine24$258
Hydroxyzine Hcl11$241
Trazodone Hcl68$225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$399$66,55622 claims
Alkermes, Inc.Aristada$232$51,26619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Manassas

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →